Physician profile
Clones Lans
NPI 1235423138
$10,779.06
in general payments reported to CMS, 2019-2025
12 companies · $56.63 in 2025
The $56.63 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,883 · 2020: $28.00 · 2021: $190 · 2022: $385 · 2023: $19.16 · 2024: $217 · 2025: $56.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,796.89 | 2019-2021 | |
| Allergan, INC. | $359.78 | 2022 | |
| Abbvie INC. | $181.48 | 2020-2021 | |
| Organon LLC | $145.87 | 2022-2024 | |
| Gilead Sciences, INC. | $88.87 | 2019 | |
| Hologic Sales and Service, LLC | $47.87 | 2019-2024 | Coolseal Generator, Omni Hysteroscope |
| Coopersurgical, INC. | $42.06 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Dexcom, INC. | $32.60 | 2025 | Dexcom G6 Transmitter |
| Millicent US INC | $24.03 | 2025 | Intrarosa, Femlyv |
| Evofem Biosciences, INC. | $21.10 | 2024 | |
| Exeltis, USA INC. | $20.83 | 2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $17.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clones Lans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.